Literature DB >> 9338783

Severe neuropathies in mice with targeted mutations in the ErbB3 receptor.

D Riethmacher1, E Sonnenberg-Riethmacher, V Brinkmann, T Yamaai, G R Lewin, C Birchmeier.   

Abstract

Neuregulins and their specific receptors, members of the ErbB family of tyrosine kinases, have been implicated in the control of growth and development of Schwann cells, specialized cells that wrap around nerve axons to provide electrical insulation. Here we use gene targeting to generate mice that lack ErbB3, a high-affinity neuregulin receptor. Homozygous erbB3 mutant embryos lack Schwann-cell precursors and Schwann cells that accompany peripheral axons of sensory and motor neurons. The initial development of motor neurons and sensory neurons of dorsal root ganglia occurs as it should, but at later stages most motor neurons (79%) and sensory neurons in dorsal root ganglia (82%) undergo cell death in erbB3 mutant embryos. Degeneration of the peripheral nervous system in erbB3 mutant pups is thus much more severe than the cell death in mice that lack neurotrophins or neurotrophin receptors. We also show that ErbB3 functions in a cell-autonomous way during the development of Schwann cells, but not in the survival of sensory or motor neurons. Our results indicate that sensory and motor neurons require factors for their survival that are provided by developing Schwann cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9338783     DOI: 10.1038/39593

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  212 in total

1.  The C-terminus of the kinase-defective neuregulin receptor ErbB-3 confers mitogenic superiority and dictates endocytic routing.

Authors:  H Waterman; I Alroy; S Strano; R Seger; Y Yarden
Journal:  EMBO J       Date:  1999-06-15       Impact factor: 11.598

2.  Signalling-competent truncated forms of ErbB2 in breast cancer cells: differential regulation by protein kinase C and phosphatidylinositol 3-kinase.

Authors:  A Esparís-Ogando; E Díaz-Rodríguez; A Pandiella
Journal:  Biochem J       Date:  1999-12-01       Impact factor: 3.857

3.  The transcription factor Sox10 is a key regulator of peripheral glial development.

Authors:  S Britsch; D E Goerich; D Riethmacher; R I Peirano; M Rossner; K A Nave; C Birchmeier; M Wegner
Journal:  Genes Dev       Date:  2001-01-01       Impact factor: 11.361

4.  Aberrant development of motor axons and neuromuscular synapses in erbB2-deficient mice.

Authors:  W Lin; H B Sanchez; T Deerinck; J K Morris; M Ellisman; K F Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

5.  Developing Schwann cells acquire the ability to survive without axons by establishing an autocrine circuit involving insulin-like growth factor, neurotrophin-3, and platelet-derived growth factor-BB.

Authors:  C Meier; E Parmantier; A Brennan; R Mirsky; K R Jessen
Journal:  J Neurosci       Date:  1999-05-15       Impact factor: 6.167

6.  p75 is important for axon growth and schwann cell migration during development.

Authors:  C A Bentley; K F Lee
Journal:  J Neurosci       Date:  2000-10-15       Impact factor: 6.167

7.  Akt-mediated survival of oligodendrocytes induced by neuregulins.

Authors:  A I Flores; B S Mallon; T Matsui; W Ogawa; A Rosenzweig; T Okamoto; W B Macklin
Journal:  J Neurosci       Date:  2000-10-15       Impact factor: 6.167

Review 8.  The ErbB signaling network: receptor heterodimerization in development and cancer.

Authors:  M A Olayioye; R M Neve; H A Lane; N E Hynes
Journal:  EMBO J       Date:  2000-07-03       Impact factor: 11.598

9.  Terminal differentiation of myelin-forming oligodendrocytes depends on the transcription factor Sox10.

Authors:  C Claus Stolt; Stephan Rehberg; Marius Ader; Petra Lommes; Dieter Riethmacher; Melitta Schachner; Udo Bartsch; Michael Wegner
Journal:  Genes Dev       Date:  2002-01-15       Impact factor: 11.361

Review 10.  ErbB-4: a receptor tyrosine kinase.

Authors:  W Zhou; G Carpenter
Journal:  Inflamm Res       Date:  2002-02       Impact factor: 4.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.